1. Assessment of myocardial viability

2. Viability – Dysfunctional myocardium subtended by diseased coronary arteries – Limited or absent scarring – Potential for functional recovery Prospective definition Reversible ischemic contractile dysfunction – Myocardial stunning – Myocardial hibernation

3. Myocardial stunning Heyndrickx et al 1978 Prolonged and fully reversible contractile dysfunction of the ischemic heart that persists after reperfusion Transient period of ischemia f/b reperfusion-depressed function at rest,preserved perfusion Affected area responsive to inotropes Time course not altered by use of inotropes- spontaneously resolve within a week Duration of stunning depends on the duration and severity of ischemia and the adequacy of arterial flow

4. Clinical relevance Exercise induced ischemia Acute cor.syndrome Angioplasty-balloon inflation Cardiopulmonary bypass

5. Mechanism Calcium hypothesis-decrease responsiveness to calcium Oxyradical hypothesis-ROS during reperfusion impairs calcium handling

6. Myocardial hibernation Diamond et al 1978 Persistent LV contractile dysfunction when myocardial perfusion is chronically reduced but sufficient to maintain viability of tissue Depressed function and perfusion at rest Progressively reversible after revascularisation Time to restoration- – Months to one year – Depend on duration and severity of flow reduction&ultrastructural changes

7. Mechanisms Smart heart hypothesis – Myocardial function &metabolism reduced to match a reduction in blood flow Repetitive stunning hypothesis – Repetitive episodes of ischemia reperfusion from supply demand mismatch leading to sustained depression of contractile function

8. Cellular mechanisms Apoptosis prominent during transition to hibernation-30%cell loss Compensatory regional myocyte hypertrophy-to maintain normal wall thickness Increase in interstitial connective tissue,myolysis,increased glycogen deposition,minimitochondria Cell survival programme-downregulation of glycogen synthase kinase,increase anti apoptotic proteins Downregulation of beta adrenergic adenylyl cyclase

9. Clinical assessment Heart failure and active angina – Directly angiography – Viability study may have a role in planning revascularisation strategy once coronary anatomy known Heart failure and no angina – Class 1 recommendation for assessment of viability in pts with CAD and LVD – Class 2a rec.for assessment of co-presence of CAD

10. STEMI – Class2a rec. for viability assessment 4 to 10 days after STEMI in hemodynamically&electrically stable pts.to define potential effect of revascularisation

11. Strong association b/w myocardial viability and improved survival after revascularization in pts with chronic CAD and LV dysfunction. – Allmann KC et al;JACC 2002 Pts with viability-revascularization a/w 79% reduction in mortality (16% vs. 3.2%) as compared to conserv.Rx Pts without viability-no significant difference in revasc. Vs medical therapy (7.7% vs. 6.2%)

14. In patients with ischemic cardiomyopathy 55% had viable myocardium by PET&27% had improved LVEF after revascularisation – Auerbach MA et al;circulation 1999

16. Techniques for assessment of viability Myocardial glucose utilisation-PET FDG Cell membrane integrity-SPECT Thallium Intact mitochondria-SPECT Tc Contractile reserve-dob.echo and dob.MRI Scar tissue-DEMRI,MSCT

17. Echocardiographic assessment LV end-diastolic wall thicknesses – Less than 6 mm-less likely to be viable

18. Dobutamine stress echo Low-dose dobutamine (5–10 μg/kg/min) – Increase contractility in viable myocardium High-dose dobutamine(upto 40 μg/kg/min) – Biphasic response –initial improvement F/B worsening – underperfused but viable tissue-most specific sign of improvement after revasc. – Uniphasic response-sustained improvement-myocardial damage with subsequent reperfusion-less predictive of improvement after revasc. – Deterioration of wall motion without initial improvement-severe ischemia – No change in wall motion-scar Sensitivity(84%),specificity(81%)for recovery of function

19. Strengths- – Higher specificity – Viability&ischemia assessed – MR can be detected – Good spatial resolution – Widely available – Lower cost – Predictive of clinical outcomes

20. Limitations – Poor window in 30% – Lower sensitivity – Viable regions with absent flow reserve will not show thickening – Reliance on visual assessment

21. Myocardial contrast echo Gas-filled microbubbles <7 μ as contrast agents Produces myocardial opacification and facilitates identification of LV borders Burst of high-intensity ultrasound-destroy microbubbles within the myocardium- replenishment observed over the next 10 to 15 cardiac cycles Viable if homogeneous contrast intensity Absence of contrast enhancement-nonviable myocardium

23. Sensitivity 89% and specificity of 51% Higher sensitivity,lower specificity compared to DSE

24. Strengths – Microcirculatory integrity – Extent of viability – Precise deleination – Viability assessed in total occlusion Limitation – Poor window – Scant clinical data

25. Myocardial strain rate imaging Determination of velocities in two segments of myocardium separated by a distance Strain rate is rate of change of velocity b/w these points Increased sensitivity from 73% to 83% compared to visual assessment

26. Echo based techniques Strengths – Safety, portability, low cost,widespread availability of equipment – Absence of radiation hazard Limitations – Operator dependent – Spatial resolution is relatively low – Diagnostic accuracy reduced in poor acoustic window

27. TMT Exercise induced ST elevation in infarct related area was associated with residual tissue viability – Margonoto et al ;JACC 1995 Sensitivity&specificity of reciprocal ST- segment depression a/w exercise-induced ST- segment elevation in prior Q wave infarct for detecting residual viability-84%&100% – Nakano A et al;JACC 1999

28. SPECT-Th-201 K+ analogue utilizes active cellular transport system-relies on intact cell Uptake depends on viability &regional perfusion Redistribution-gradual accumulation of tracer in hypoperfused areas,rapid washout from normally perfused areas Segments with tracer uptake >60%-viable Subendocardial scar tissue may be labelled as viable-lower specificity

29. Rest redistribution protocols- – Defects in initial images that improve in 4 hour image-viable myocardium – Additional 24 hr image if fixed defects in 4 hr image – S/L NTG prior to injection – Less sensitive-86%,specificity 47%

30. Rest redistribution thallium-defect in inferoseptal wall that redistributes

31. Stress redistribution protocol – Pharmac.or exercise stress – Th inj. &imaging f/b 4 hr image – Myocardium not perfused with rest or stress-scar – Defect on stress and improves on rest-ischemic &viable – 24 hr image for late redistribution

32. Stress redistribution reinjection protocols – Reinjection of Th201 and image repeated 24hr later – Viable myocadium-uptake of tracer on reinjection in segments with no uptake on stress – Scar –defect that persists – Sensitivity 90% specificity 54%

33. Tc99m labelled agents Rely on sarcolemmal integrity and mitochondrial function Short half life,higher doses,better image Redisribution less-less helpful in assessing viability Tc NOET-similar redistribution kinetics to Thallium Viability criterion is>50% tracer uptake in dysfunctional segments.

34. Ant Inf Lat Sep Apex  Base Ant Inf Apex Septum  Lateral Apex Sep Lat Inferior  Anterior Stress Rest Reversible Ischeamia, defect appears at stress and disappears during rest

35. Ant Inf Lat Sep Apex  Base Ant Inf Apex Septum  Lateral Apex Sep Lat Inferior  Anterior Stress Rest Fixed Scar, defect is seen in both stress and rest

36. Strengths – High sensitvity – Quantitative objective criteria – LVEF – FDG with special collimator – Predictive of outcomes

37. Limitations – Reduced spatial resolution &sensitivity compared to PET – Attenuation artefacts – Cannot differentiate endocardial viability – Less quantitative than PET

38. SPECT FDG High energy collimators to detect regional FDG uptake by SPECT camera. Concordance between 18FDG SPECT and 18FDG PET was 95% Sensitivity of 88% and specificity of 73% as compared to PET – Srinivasan G et al;circulation 1998 Increases sensitivity to detect viability compared to Thallium

39. PET Positron emitting isotopes releasing 2 photons at angle180,detected by camera by coincidence counting to give a higher resolution Perfusion tracers-N13 ammonia,Rb 82,O15 water Metabolic tracers- F18DG,C11acetate,C11 palmitate FDG taken up by viable cells,phoshorylated&trapped inside Poor uptake in diabetics

40. Interpretation Normal perfusion-viability Flow metabolism mismatch-reduced perfusion with intact metabolism-hibernating viable myocardium Flow metabolism match-impaired FDG uptake with reduced perfusion-scar Gold standard for assessment of viability

42. Perfusion metabolism mismatch-apex,anterior anterolateral wall

43. Strengths- – Perfusion &metabolism – More sensitive – No attenuation – Absolute blood flow can be measured – Predictive of outcomes

44. Limitations – Lower specificity to dob.echo&MRI – Cannot differentiate b/w endocardial and epicardial viability – High cost – Limited availability

45. Cardiac MRI Preserved wall thickness >5.5mm correlated with PET viability(sen.95%,spe.41%) – Baer FM et al;circulation 1995 Dobutamine cine MRI – Improved thickening>2mm by low dose dobutamine CMR(sen. 73%,spe.83%) – Higher accuracy than dobutamine echo – Monitoring difficult Delayed enhancement MRI(DEMRI) – Sen.95%,spe.45%

46. DEMRI using Gadolinium based agents (i.v.0.2 mmol/kg) Extracellular space Infarcted or scarred tissue-interstitial spaces larger-delayed wash in &delayed wash out Hyperenhanced area of myocardium on images taken 10 to 20 min after contrast Size and shape of infarct correlate with histology

49. Scarring begins at subendocardial surface and extends toward epicardium Transmural extent of infarct used to determine viability of each segment Likelihood of functional improvement inversely related to TEI 78%with no hyperenhancement improved,only 2% with >75% TEI improved – Kim RJ et al;NEJM 2000

56. Mean TEI 10%-Improved contractility after revasc. Mean TEI 41%-no improvement in contractility

57. Nuclear scintigraphy-% of viability in a given segment is assessed indirectly DEMRI-direct assessment of viability in a given segment

59. Indirect method show only 39% viability,direct method gives 70% viability-proven by revascularisation Mean transmural extent predicted irreversibility-41% by MRI,35% by histology DEMRI superior sensitivity&specificity to SPECT;similar sensitivity and superior specificity to PET

60. Strengths – Accurate assessment of extent of scar – Superior spatial resolution – Wall thickness correctly measired – Simultaneous assessment of perfusion,function and viability – Good imaging windows

61. Limitations – High cost – Limited availability – Longer time – Contra.with implanted ferromagnetic objects – Gadolinium contra.in CKD with GFR<30ml/min – Claustrophobia – Irregular rhythems – Breathholding required

62. MSCT Iodinated contrast agents accumulate in infarcted myocardium similar to DEMRI High spatial resolution-differentiation of transmural &subendocardial infarction possible Old infarctions have lower CT densities compared to recent infarcts Good agreement b/w DEMRI and late enhancement of MSCT

63. subendocardial hyperenhancement of the posterior wall

64. 64-Slice Computed Tomography hyperenhancement of the inferior wall

65. Sensitivity&specificity -92%& 100% respectively to detect viability in acute myocardial infarction Presence of viable segments in an AMI identified when hyperenhancement is absent or involves <50% of the myocardial wall thickness Advantages – Shorter imaging time – widely available

66. Extent of viability Magnitude of improvement depends on quantitative extent of myocardial viability 25% of the LV should be viable by DSE&38% by nuclear imaging

67. Comparison of different techniques Baer FM,European heart journal 2000 – Higher accuracy for dob.TEE and dob.MRI for predicting improvement in LV function post revasc.

69. Comparison-DSE,MCE,SPECT shimoni et al;circulation2003

70. PET and SPECT have higher sensitivity &DSE has higher specificity for assessing viability – Robert Bonow;JACC 2002 Magnitude of improvement in outcome with revascularization did not differ whether assessed by PET,SPECT or DSE

73. DEMRI vs PET KLEIN et al;circulation 2002

74. DSE Vs nuclear imaging Sensitivity 90% for nuclear imaging,74% for DSE Specificity 57% for nuclear imaging,78% for DSE – Bax JJ et al;2002 Integration of both may be useful

75. Survival benefit